SpectraBase Spectrum ID |
2MGG0cbAoAp |
Name |
N-Benzylpiperazine |
CAS Registry Number |
2759-28-6 |
Classification |
Piperazine designer drug |
Comments |
Spectrum verified by crosschecking against external libraries (one reference spectrum with similarity >= 99% found); Spectrum verified by independent measurements in external laboratories |
Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
DEA Citation |
21 CFR §1308.11 (f) (3) |
DEA Controlled Substance Name |
N-Benzylpiperazine |
DEA Controlled Substance Type |
Salts, isomers, and salts of isomers |
DEA Controlled Substances Code Number |
7493 |
DEA Schedule |
Schedule I |
DEA Section |
Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers. |
Exact Mass |
176.131348523 u |
Formula |
C11H16N2 |
InChI |
InChI=1S/C11H16N2/c1-2-4-11(5-3-1)10-13-8-6-12-7-9-13/h1-5,12H,6-10H2 |
InChIKey |
IQXXEPZFOOTTBA-UHFFFAOYSA-N |
Ionization Type |
Electron Ionization (EI) |
Molecular Weight |
176.263 g/mol |
Nominal Mass |
176 u |
Quality |
1000 |
Retention Index |
1474 |
SMILES |
C(N1CCNCC1)C1=CC=CC=C1 |
SPLASH |
splash10-000x-9600000000-ae208c0d36cf2d066e5e |
Source of Spectrum |
DigiLab GmbH (C) 2024 |
Synonyms |
BZP
1-Benzylpiperazine |
Technique |
GC/MS |
Wiley ID |
DD2024_008274 |